Gallopamil
![]() | |
Systematic (IUPAC) name | |
---|---|
(RS)-5-[2-(3,4-Dimethoxyphenyl)ethyl-methylamino]-2-propan-2-yl-2-(3,4,5-trimethoxyphenyl)pentanenitrile | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number |
16662-46-7 16662-47-8 |
ATC code | C08DA02 |
PubChem | CID 1234 |
ChemSpider |
1197 ![]() |
UNII |
39WPC8JHR8 ![]() |
KEGG |
D01969 ![]() |
ChEMBL |
CHEMBL51149 ![]() |
Chemical data | |
Formula | C28H40N2O5 |
Molar mass | 484.62 g/mol |
Chirality | Racemic mixture |
| |
| |
![]() ![]() |
Gallopamil (INN) is a L-type calcium channel blocker, that is an analog of verapamil. It is used in the treatment of cardiac arrhythmias.[1]
References
- ↑ Sewing K-F, Hannemann H (1983). "Calcium Channel Antagonists Verapamil and Gallopamil Are Powerful Inhibitors of Acid Secretion in Isolated and Enriched Guinea Pig Parietal Cells". Pharmacology 27: 9–14. doi:10.1159/000137824.
This article is issued from Wikipedia - version of the Saturday, February 27, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.